Navigation Links
EUCODIS Bioscience Appoints Thomas Fischer as New CEO
Date:12/7/2009

VIENNA, Austria, December 7 /PRNewswire/ -- EUCODIS Bioscience, a company developing, customizing, manufacturing, and marketing enzymes for the chemical industry, announced today that it has appointed Mr Thomas Fischer, currently CFO, as new CEO of the Company. Going forward, EUCODIS Bioscience' sole focus will be to provide high-performance enzymes to customers, capitalizing on the Company's experience in commercial enzyme development and on its proven technology of "in vivo recombination".

In line with this move EUCODIS Bioscience will spin out its French research subsidiary in a management buy-in lead by Rudy Pandjaitan, PhD, previously CEO of EUCODIS Bioscience.

Dr. Pandjaitan will acquire a majority stake in the new entity. Under his leadership the new entity will develop next-generation applications of "in vivo recombination". EUCODIS Bioscience will retain a strategic share in its former subsidiary.

"White Biotechnology, or enzyme-based products and manufacturing, is a 100 billion Euro market, and EUCODIS Bioscience is well positioned to exploit the huge commercial potential of this business", said Thomas Fischer, CEO of EUCODIS Bioscience. "It was under Rudy's leadership that the Company has developed into this position, and we are pleased that he will continue to actively support EUCODIS Bioscience in the area of business development as a consultant."

"EUCODIS Bioscience' technology is a powerful and proven tool for the creation of novel enzymes", said Dr. Pandjaitan. "Even more fascinating, in vivo recombination may also be used in synthetic biology, generating DNA strands of more than 10,000 base pairs on a routine basis. It is our vision that in vivo recombination will enable the creation of novel pathways and even whole genomes, providing a key technology for the 'cellular factory' of the future."

"In vivo recombination" is EUCODIS Bioscience' proprie
'/>"/>

SOURCE EUCODIS Bioscience
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus
2. EUCODIS Bioscience Launches Lipase Portfolio
3. EUCODIS Bioscience Launches Beta-Lactamase for Antibiotics and Diagnostics Industries
4. EUCODIS Bioscience Signs Research Agreement With Genencor
5. EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone
6. EUCODIS Bioscience Appoints Thomas Fischer as Chief Financial Officer
7. Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc.
8. Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops
9. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
10. YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA
11. American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... November 26, 2014 On January, 14, ... Baltimore and Washington D.C. science community to the UMBC ... event, sponsored by the Protein Society, will take place ... Center, Room 312. Through discussion, presentations and workshops, ... importance of proteins, their role in the industry and ...
(Date:11/26/2014)... Silicon Valley Electronic Data Capture (EDC) provider ... provider of clinical research and data management services to ... its CRO Partnership Program, Clinovo expands ClinCapture , ... , “We have found Clinovo’s ClinCapture to exceed our ... is both user friendly and easy to deploy. The ...
(Date:11/26/2014)... November 26, 2014 SoundConnect , ... is proud to announce that Darren Suders has joined ... Darren will drive the partner program ... experience. , Darren brings more than 10-years ... key roles in channel operations, from policy development, to ...
(Date:11/26/2014)... Theravalues Corporation annuncia con orgoglio il lancio di Theracurmin® ... Europe 2014 (dal 2 al 4 dicembre, ... con la maggiore biodisponibilità di sempre, con una combinazione ... norme europee. La curcumina è un pigmento ... longa ) che è stata associata con attività antiossidanti, ...
Breaking Biology Technology:RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 2SoundConnect Appoints Director of Channel Development & Sales 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3
... 2008 The American Ceramic Society and the ... released ACerS-NIST Phase Equilibria Diagrams CD-ROM Database (Version ... evaluated phase diagrams of ceramic systems such as ... chalcogenides, and features over 1,000 new diagrams. , ...
... Directors of Schering-Plough Corporation (NYSE: SGP ) today declared ... will be made on Feb. 27, 2009, to shareholders of record ... of Sept. 30, 2008, there were 1,626,234,628 common shares outstanding. ... today also declared a quarterly dividend of $3.75 per share on ...
... Dec. 10 Nuvelo, Inc.,(Nasdaq: ... the Phase 1 trial of,recombinant, secreted protein, ... Wnt,Therapeutics Program. This single-center, double-blind, placebo-controlled,single-ascending dose ... of a single intravenous (IV) administration of ...
Cached Biology Technology:The American Ceramic Society releases new ACerS-NIST phase equilibria diagrams CD-ROM database 2Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers 2Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers 3Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers 4Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers 5
(Date:11/7/2014)... , Nov. 7, 2014  In conjunction with the ... Police Departments, The Community Foundation of the Verdugos has ... DNA JUSTICE PROJECT," a $250,000 initiative to keep the ... phase. In its first six months of existence, the Lab ... evidence support for local law enforcement. "Because our ...
(Date:11/6/2014)... deaths occur because of metastasis, yet progress in ... slow. , "It,s been particularly challenging to design ... research fellow in systems biology at Harvard Medical ... until after they,ve already metastasized." , Gujral and ... should help researchers better understand how metastasis begins. ...
(Date:11/5/2014)... professor of biology in the UTSA College of ... nation selected to receive a two-year $300,00 National ... Research (EAGER). The funding supports President Obama,s BRAIN ... create new technology that will demystify complex brain ... in neuroscience are broken into the interactions of ...
Breaking Biology News(10 mins):Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Migration negation 2Migration negation 3UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3
... Four million people die every year from respiratory diseases such as ... dangerous. What is more, the flu vaccine is not as effective ... reason for this is that with age the fire power of ... largely unknown. An international EU project led by the University of ...
... vitamin in an attempt to defeat drug screening tests may ... from The Children's Hospital of Philadelphia and The University of ... toxic side effects from taking large amounts of niacin, also ... drug tests. , Both adult patients suffered skin ...
... technique pioneered by Dr Amanda Hayes and her UNSW ... cells to airborne toxicants and measures cytotoxic effects. The ... a small diffusion chamber and then exposed to selected ... exposure, they can study cell growth and metabolism, and ...
Cached Biology News:Fighting influenza & co. with 40,000 blood samples 2Fighting influenza & co. with 40,000 blood samples 3Misusing vitamin to foil drug test may be toxic; plus, it doesn't work 2Soft-cell approach cuts animal tests 2Soft-cell approach cuts animal tests 3
Can be used for the quantitative recovery of small amounts of nucleic acids within dilute solutions. 5mg/ml...
APOPTAG® Plastic Coverslips are designed to be custom fitted to the specific APOPTAG® kit application. Each coverslip has 2.5 x 1 dimensions....
Human VEGF-D Biotinylated MAb (Clone 78923)...
Recombinant Mouse TGF-beta RII/(human) Fc Chimera, CF...
Biology Products: